Tonghua Dongbao Pharmaceutical Co (SHSE:600867) Accounts Payable & Accrued Expense : ¥194 Mil (As of Mar. 2024)

View and export this data going back to 1994. Start your Free Trial

What is Tonghua Dongbao Pharmaceutical Co Accounts Payable & Accrued Expense?

Tonghua Dongbao Pharmaceutical Co's quarterly accounts payable & accrued expense increased from Sep. 2023 (¥180 Mil) to Dec. 2023 (¥359 Mil) but then declined from Dec. 2023 (¥359 Mil) to Mar. 2024 (¥194 Mil).

Tonghua Dongbao Pharmaceutical Co's annual accounts payable & accrued expense declined from Dec. 2021 (¥260 Mil) to Dec. 2022 (¥140 Mil) but then increased from Dec. 2022 (¥140 Mil) to Dec. 2023 (¥359 Mil).

Tonghua Dongbao Pharmaceutical Co Accounts Payable & Accrued Expense Historical Data

The historical data trend for Tonghua Dongbao Pharmaceutical Co's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tonghua Dongbao Pharmaceutical Co Accounts Payable & Accrued Expense Chart

Tonghua Dongbao Pharmaceutical Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

149.90

199.70

260.41

140.35

359.41

Tonghua Dongbao Pharmaceutical Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															160.02	192.27	180.24	359.41	194.38

Tonghua Dongbao Pharmaceutical Co Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Tonghua Dongbao Pharmaceutical Co (SHSE:600867) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Tonghua Dongbao Pharmaceutical Co Ltd (SHSE:600867) » Definitions » Accounts Payable & Accrued Expense

Traded in Other Exchanges

N/A

Address

Dongbao Village, Jilin Province, Tonghua, CHN, 134123

Website

http://www.thdb.com

Tonghua Dongbao Pharmaceutical Co Ltd is a China-based firm. Its engaged in the production and distribution of pharmaceutical products. Its products include human insulin injection, Heart and brain capsule, Vitamin e soft capsule, and Oral detoxification products.

Executives

Cheng Jian Qiu	Supervisors
Chang Xiao Hui	Director
Li Cong	Director
Li Feng Qin	Director
Chen Hong	senior management
Leng Chun Sheng	Director
Li Yi Kui	Director
Wang Dian Duo	Supervisors
Wang Jun Ye	Director
Han Jie	Director

Tonghua Dongbao Pharmaceutical Co (SHSE:600867) Headlines

No Headlines